DrugPatentWatch Database Preview
Drugs in Development Information for VTP-194204
» See Plans and Pricing
What is the development status for investigational drug VTP-194204?
VTP-194204 is an investigational drug.
There have been 18 clinical trials for VTP-194204.
The most recent clinical trial was a Phase 3 trial, which was initiated on January 21st 2019.
The most common disease conditions in clinical trials are Prostatic Neoplasms, Psoriasis, and Erectile Dysfunction. The leading clinical trial sponsors are Steba Biotech S.A., Vitae Pharmaceuticals, Inc., and STEBA France.
There are twenty US patents protecting this investigational drug and sixty-one international patents.
Summary for VTP-194204
| US Patents | 20 |
| International Patents | 61 |
| US Patent Applications | 34 |
| WIPO Patent Applications | 157 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2019-01-21) |
| Vendors | 15 |
Recent Clinical Trials for VTP-194204
| Title | Sponsor | Phase |
|---|---|---|
| ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study | Medpace, Inc. | Phase 3 |
| ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study | PrimeVigilance | Phase 3 |
| ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study | Steba Biotech S.A. | Phase 3 |
Clinical Trial Summary for VTP-194204
Top disease conditions for VTP-194204
Top clinical trial sponsors for VTP-194204
US Patents for VTP-194204
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| VTP-194204 | Start Trial | Autoimmune disorder treatment using RXR agonists | lo Therapeutics, Inc. (Santa Ana, CA) | Start Trial |
| VTP-194204 | Start Trial | Treatment of cancer with specific RXR agonists | Io Therapeutics, Inc. (Santa Ana, CA) | Start Trial |
| VTP-194204 | Start Trial | Treatment of cancer with specific RXR agonists | IO Therapeutics, Inc. (Santa Ana, CA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for VTP-194204
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| VTP-194204 | Australia | AU2012352149 | 2031-12-13 | Start Trial |
| VTP-194204 | Australia | AU2017210644 | 2031-12-13 | Start Trial |
| VTP-194204 | Canada | CA2858882 | 2031-12-13 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
